Putting Science to Work

Archives / 2018 / November

  • Syngene International net up by 1.7% in Q2

    PharmaBiz- 25/10/2018. Both our Discovery Services and Dedicated Centre verticals performed well, with the later benefiting from expansions announced earlier in the year of our collaboration with Baxter.


Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget